FindTrial
Sign In

Clinical characteristics of patients with hyperlipidemia or hyperamylasemia: an observational study

Clinical characteristics of patients with hyperlipidemia or hyperpamylase: a observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046646
Enrollment
Unknown
Registered
2021-05-24
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperlipidemia, hyperamylasemia

Interventions

case series:No

Sponsors

Department of Gastroenterology, the First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 90 years; 2. Complete the detection of serum lipase and serum amylase; 3. Complete at least one abdominal imaging examination (ultrasound, CT, MRI or PET-CT, etc.).

Exclusion criteria

Exclusion criteria: 1. Serum lipase and amylase were 3 times lower than the upper limit of normal reference value; 2. The following diseases were excluded: acute pancreatitis, parotitis, parotid gland tumor, cholangiopancreatic duct tumor, duodenal tumor, splenic aneurysm, abdominal aortic stenosis, abdominal aortic aneurysm, etc.

Design outcomes

Primary

MeasureTime frame
Serum lipase;Serum amylase;—

Countries

China

Contacts

Public ContactLi Suwen

The First Affiliated Hospital of Anhui Medical University

ahmuxiaoli@163.com+86 13909697862

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026